• 1
    Monaco JJ. A molecular model of MHC Class-I-restricted antigen processing. Immunol Today 1992; 13:1739.
  • 2
    Bland PW, Warren LG. Antigen presentation by epithelial cells of the rat small intestine. I. Kinetics, antigen specificity and blocking by anti-Ia antisera. Immunology 1986; 58:17.
  • 3
    Mayer L, Shlien R. Evidence for function of Ia molecules on gut epithelial cells in man. J Exp Med 1987; 166:147183.
  • 4
    Rognum TO, Thrane PS, Stoltenberg L, Vege A, Brandtzaeg P. Development of intestinal mucosal immunity in fetal life and the first postnatal months. Pediatr Res 1992; 32:1459.
  • 5
    Hughes A, Bloch KJ, Bhan AK, Gillen D, Giovino VC, Harmatz PR. Expression of MHC Class II (Ia) antigen by the neonatal enterocyte: the effect of treatment with interferon-gamma. Immunology 1991, 72:4916.
  • 6
    Cerf-Bensussan N, Quaroni A, Kurnick JT, Bhan AK. Intraepithelial lymphocytes modulate Ia expression by intestinal epithelial cells. J Immunol 1984; 132:224452.
  • 7
    Sidhu NK, Wright GM, Markham RJF, Ireland WP, Singh A. Quantitative regional variation in the expression of major histocompatibility Class II antigens in the enterocytes of the mouse small intestine. Tissue Cell 1992; 24:2218.
  • 8
    Mayer L, Eisenhardt D, Salomon P, Bauer W, Pious R, Piccinini L. Expression of Class II molecules on intestinal epithelial cells in humans. Gastroenterology 1991; 100:312.
  • 9
    Kelly J, O'Farrelly C, O'Mahoney D, Weir DG, Feighery C. Immunoperoxidase demonstration of the cellular composition of the normal and coeliac small bowel. Clin Exp Immunol 1987; 68:17788.
  • 10
    Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 1987; 105:103945.
  • 11
    Czarniecki C, Chiu HH, Wong GHW, Me Cabe SM, Palladino MA. Transforming growth factor β1 modulates the expression of Class II histocompatibility antigens on human cells J Immunol 1988; 140:421723.
  • 12
    Zuber P, Kuppner MC, de Tribolet N. Transforming growth factor-β2 down-regulates HLA-DR antigen expression on human malignant glioma cells. Eur J Immunol 1988; 18:16236.
  • 13
    Cox DA, Bürk RR. Isolation and characterisation of milk growth factor, a transforming-growth-factor-β2-related polypeptide, from bovine milk. Eur J Biochem 1991; 197:3538.
  • 14
    Jin Y, Cox DA, Knecht R, Raschdorf F, Cerletti N. Separation, purification and sequence identification of TGF-β1 and TGF-β2 from bovine milk. J Protein Chem 1991; 10:56575.
  • 15
    Phillips JO, Everson MP, Moldoveanu Z, Lue C, Mestecky J. Synergistic effect of IL-4 and IFN-γ on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J Immunol 1990; 145:17404.
  • 16
    Zweibaum A, Pinto M, Chevalier G et al. Enterocyte differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and us inhibition by glucose. J Cell Physiol 1985; 122:2129.
  • 17
    Cerf-Bensussan N, Schneeberger EE, Bhan AK. Immunohistologic and immunoelectron microscopic characterization of the mucosal lymphocytes of human small intestine by the use of monoclonal antibodies. J Immunol 1983; 130:261522.
  • 18
    Hoang P, Crotty B, Dalton HR, Jewell DP. Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes. Gut 1992; 33:108993.
  • 19
    Flynn RM, Palladino MA. TNF and TGF-β:the opposite sides of the avenue. In:BeutlerB, ed. Tumor necrosis factors:the molecules and their emerging role in medicine, 1st edn. New York :Raven, 1992:13144.
  • 20
    Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor-β:biological function and chemical structure. Science 1986; 233:5324.
  • 21
    Huggett AC, Ellis PA, Ford CP, Hampton LL, Rimoldi D, Thorgeirsson SS. Development of resistance to the growth inhibitory effects of transforming growth-β1 during the spontaneous transformation of rat liver epithelial cells. Cancer Res 1991; 51:592936.
  • 22
    Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard M, Palladino MA. Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 1987; 166:5716.
  • 23
    Barnard JA, Beauchamp RD, Coffey RJ, Moses HL. Regulation of intestinal epithelial cell growth by transforming growth factor type β. Proc Natl Acad Sci USA 1989; 86:157882.
  • 24
    Koyama S-Y, Podolsky DK. Differential expression of transforming growth factors α and β in rat intestinal epithelial cells. J Clin Invest 1989; 83:176873.
  • 25
    Lamprecht SA, Schwartz B, Glicksman A. Transforming growth factor-beta in intestinal epithelial differentiation and neoplasia. Anticancer Res 1989; 9:187781.
  • 26
    Altman DJ, Schneider SL, Thompson DA, Cheng H-L, Tomasi TB. A transforming growth factor β2 (TGF-β2)-like immunosuppressive factor in amniotic fluid and localization of TGF-β2 mRNA in the pregnant uterus. J Exp Med 1990; 172:1391401.
  • 27
    Zhang Z, Michael JG. Orally inducible immune unresponsiveness is abrogated by IFN-γ treatment. J Immunol 1990; 144:41635.
  • 28
    Roberts AB, Sporn MB. The transforming growth factor-βs. In:SpornMB, RobertsAB, eds. Handb Exp Pharm 95, Vol. 1. Peptide growth factors and their receptors I, 1st edn. Berlin :Springer-Verlag, 1990:Chapter 8, 41972.
  • 29
    Brandtzaeg P, Halstensen TS, Huitfeldt HS, Krajci P, Kvale D, Scott H, Thrane PS. Epithelial cell expression of HLA, secretory component (Poly-Ig receptor), and adhesion molecules in the human alimentary tract. Ann NY Acad Sci 1992; 664:15779.
  • 30
    Lowes J R, Radwan P, Priddle JD, Jewell DP. Characterisation and quantification of mucosal cytokine that induces epithelial histocompatibility locus antigen-DR expression in inflammatory bowel disease. Gut 1992; 33:3159.
  • 31
    Shull MM, Ormsby I, Kier AB et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992; 359:6939.